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Abstract
 .Extracellular adenosine triphosphate ATPo has been suggested to play a role in lymphocyte effector functions.
Recently, it has been suggested that MgATP2y may be the molecular species which is involved in modulating the lytic
 .interaction between cytotoxic T-lymphocytes CTL and their target cells. In this study, we provide evidence that ATPo
mediates the phosphorylation of extracellular proteins on T-lymphocytes through the action of ectoprotein kinases. The
ectophosphorylation is temperature-dependent, supported by Mg2q and Mn2q, and both ATP and GTP, whereas kinase
activity andror substrates were removed by pretreatment of intact lymphocytes with trypsin. We show the presence of
extracellular ATPrGTP-binding sites, indicating the presence of ectoenzymes on intact lymphocytes. The major ectoprotein
kinase was identified as a casein kinase II-like protein kinase and could be inhibited by heparin, whereas its activity was
enhanced by spermine. The ectoprotein kinase showed remarkable substrate specificity, phosphorylating the serum protein
vitronectin, but not fibronectin. In experiments with the cell-impermeable protein kinase inhibitor K-252b, we demonstrate
the possible functional importance of ectoprotein kinase in CTL-mediated cytotoxicity, i.e., target cell death was completely
blocked by K-252b without affecting intracellular phosphorylation. These results suggest that ectoprotein phosphorylation
may possibly be an important event in immunologically relevant cell–cell interactions. q 1997 Elsevier Science B.V.
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1. Introduction
 .Extracellular ATP ATPo was strongly implicated
as a fast excitatory transmitter in synaptic transmis-
w xsion 1 and in neuronal events associated with mem-
ory formation, probably by interaction with puriner-
gic receptors, ecto-ATPases and phosphorylation by
ectoprotein kinases. In addition, ATPo was shown to
mediate cell–cell spread of calcium signals between
w xmast cells through purinergic receptors 2 . Moreover,
purinergic receptors, as well as extracellular phospho-
rylation, were suggested to be involved in the cell–cell
contacts leading to activation of T-lymphocytes T-
. w xcell-mediated cytotoxicity 3–7 .
Recently, antigen receptor-triggered accumulation
w xof ATPo 3 was demonstrated in both T-helper and
 .cytotoxic T-lymphocytes CTL . Understanding the
mechanism of this ATPo accumulation has been fur-
thered with the finding that a multi-drug resistance
 .mdr1 gene product served as an ATP channel,
mediating the release of intracellular ATP into the
w xextracellular space 8 . In the past few years, ATPo
was proposed as an important component of an alter-
native cytotoxic pathway in the mechanism of cell-
mediated cytotoxicity. It was found that ATPo can
induce target cell death through interaction with
purinergic receptors inducing colloid-osmotic lysis
w xand DNA fragmentation 8,9 or possibly through
w xother ectoenzyme systems 5 , whereas the presence
of highly active ecto-ATPases was shown to explain
the refractoriness of the effector T-cells to the lytic
w xproperties of ATPo 4 .
Comparative studies on the molecular require-
ments for the CTL-mediated cytotoxic effector func-
tions revealed the requirement of extracellular Mg2q,
even in an adhesion molecule-independent retargeted
cytotoxicity assay. This pointed to the importance of
MgATP2y as a likely participant in the induction of
w xcell-mediated cytotoxicity 5 . While originally ATPo
was considered as a candidate lytic intermediate in
w xCTL’s effector functions 4,6,7 , it is likely that
ATPo is involved in more complex and tightly regu-
lated processes of lymphocyte function. This, in turn,
attracted our attention to the possible involvement of
2y MgATP -utilizing ectoprotein kinases plasma
membrane-associated andror releasable into extracel-
.lular space .
In this report, we describe the presence of ectopro-
tein kinase activity on T-cells. In the presence of
ATPo, these kinases are able to phosphorylate lym-
phocyte surface proteins. The major ectoprotein ki-
nase, which utilized ATPo in lymphocytes, is identi-
 .fied as a casein kinase-II CKII -like protein kinase.
The effect of cell membrane-impermeable protein
kinase inhibitors suggest the involvement of these
enzymes in CTL-mediated cytotoxicity, likely on the
level of cell–cell contacts. Thus, according to our
current model, cell–cell contacts during the immuno-
logically relevant interactions, e.g. thymocyte differ-
entiation, CTLrtarget cell and T-helper cellrantigen
presenting cells interactions, can be regulated by
ATPo at the level of purinergic receptors S. Apasov,
M. Koshiba and M. Sitkovsky, manuscript in prepara-
.tion or through the ectophosphorylation of function-
ally important plasma membrane proteins.
2. Experimental procedures
2.1. Cells
 d.CTL clone OE4 anti H-2 was maintained as
w xdescribed earlier 3 , using irradiated stimulator cells
and an IL-2-containing supernatant from PMA-
stimulated EL-4 cells. Peritoneal exudate CTL and
 .alloimmune peritoneal exudate lymphocytes PEL
with BALBrc anti-EL-4 specificity were obtained 5
days after secondary i.p. immunization of BALBrc
6 mice with 25=10 EL-4 tumor cells grown as
.ascites in syngeneic C57BLr6 mice . PEL were puri-
fied from crude peritoneal exudate cells by removal
of macrophages and other adherent cells on nylon
 .wool columns 60 min, 378C followed by elution of
 .the non-adherent PEL. EL-4 cells T-cell lymphoma
 .and 2B4 cells T-helper hybridoma were maintained
in RPMI 1640 supplemented with 10% FCS Bio-
.fluids, Inc., Rockville, MD . To maintain cells in
serum-free conditions, RPMI 1640 media supple-
mented with 1% Nutridoma Boehringer, Indianapo-
..lis, IN and 1% bovine serum albumin or AIM-V
 .medium Gibco-BRL, Gaithersburg, MD were used.
Cytotoxic T-cell hybridomas PN37, MD45, MD90,
and MD45-27J were cultured in RPMI 1640 supple-
mented with 10% FCS. Cytotoxic T-cell hybridomas
were kindly provided by Dr. G. Berke Weizmann
.Institute, Israel . Shortly before each experiment, cells
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were centrifuged over FicollrHypaque to remove
dead cells and cell debris. Cells were washed three
times with HBSS, 10 mM HEPES, 10 mM MgCl ,2
pH 7.4, before assay for ectokinase activity, since it
was shown that FCS could contain protein kinase
activity. Moreover, no differences in ectokinase activ-
ity nor in the phosphorylation pattern were found in
2B4 cells grown in 10% FCS or in serum-free medium
 .data not shown , excluding the possible interference
of soluble serum-derived kinases.
2.2. Ectoprotein kinase assay
 6.Cells 10=10 were resuspended in 200 ml
HBSS, 10 mM HEPES, 10 mM glucose, 10 mM
 .MgCl or concentration indicated in figures , pH 7.42
 .reaction buffer , and preincubated for 5 min at 378C.
Ectophosphorylation was started by addition of 10
w 32 x  . mCi g- P ATP 3000 Cirmmol Amersham, Ar-
. w 32 x  .lington Heights, IL or g- P GTP 3000 Cirmmol
w 32 x  . or a- P ATP 3000 Cirmmol, as a control final
.NTP conc. 16.6 nM , and the reaction mixture was
incubated for 10 min at 37 or 48C. 10 mM cold ATP
was also included in some experiments. To stop the
reaction, samples were placed on ice, centrifuged 5
.min, 1200 rpm, 240=g , and the supernatant re-
moved. To analyze the released phosphorylated pro-
teins, 5=Laemmli sample buffer was added to the
supernatant.
The cell pellets were washed twice by centrifuga-
 .tion 5 min, 1200 rpm, 240=g with reaction buffer
supplemented with or without phosphatase inhibitors
0.4 mM vanadate, 10 mM NaF, 10 mM orthophos-
.phate . Cells were lysed in 50 ml Laemmli sample
buffer and subsequently sonicated for 10 s. Before
analysis by SDS–PAGE, samples were reduced with
100 mM DTT and boiled for 3 min. Samples were
analyzed on 4–20% or 10–20% polyacrylamide gels
 .ISSrEnprotech, Natick, MA . Following elec-
trophoresis, gels were stained with Coomassie Bril-
liant Blue, destained, dried, and subjected to auto-
radiography using Kodak XAR-2 film. In these ex-
periments, we used 2B4 or CTL-OE4 cloned cells in
parallel experiments. Mouse spleen or thymus cells
were also tested immediately after harvesting in vivo.
Very similar results were obtained with both cell
types. In some experiments, the intensity of phospho-
rylation of different bands on the same autoradio-
graph was evaluated using computer-assisted den-
sitometry Image QuantJ, Molecular Dynamics, Sun-
.nyvale, CA .
To demonstrate the substrate specificity of ectoki-
 5nases, intact CTL OE4 or 2B4 5=10 cellsr200
.  .ml were mixed with 10 mg vitronectin Gibco-BRL
 .or 20 mg fibronectin Telios, San Diego, CA in
 .serum-free AIM-V medium Gibco-BRL supple-
mented with 10 mM MgCl . Phosphorylation was2
w 32 x started by adding 10 mCi of g- P ATP final ATP
.conc. 16.6 nM , and samples were incubated for 10
min at 378C. After incubation, the cells were cen-
 .trifuged 5 min, 1200 rpm, 240=g , and super-
natants were collected. The cell pellets were washed
twice with HBSS and supplemented with cold ATP
and phosphatase inhibitors as described above. Super-
natants and cell pellets were mixed with Laemmli
sample buffer and subjected to SDS–PAGE under
reducing conditions. Gels were stained to confirm the
presence of vitronectin or fibronectin and dried. The
extent of phosphorylation was determined by auto-
 .radiography using XAR-2 film Kodak . To check for
autophosphorylation of vitronectin or fibronectin,
identical incubations were carried out in the absence
of cells.
2.3. Control experiments for use of extracellular ATP
during ectokinase assay and for ectodomain
localization of phosphorylated amino acid residues
 6To deplete extracellular ATP, cells 5=10 to
6.10=10 were resuspended in 200 ml of reaction
buffer with 10 mM MgCl and were preincubated for2
5 min in the presence of 80 Urml of hexokinase
 . Boehringer or 100 Urml apyrase Sigma, St. Louis,
.MO . The reaction was started by adding 10 ml of
w32 x  .P ATP final ATP conc. 16.6 nM to the reaction
mixture and continuing the incubation for an addi-
tional 10 min. The reaction was stopped, and samples
were treated as described above.
To measure the possible contribution of intra-
cellular phosphorylation, 10 mCi of 32P-orthophos-
phate or 10 mCi of 32P-pyrophosphate was added to
the samples to start the reaction. Measurement of the
effect of competition with cold ATP analog on ec-
tophosphorylation were performed by adding 100
 .mM AMP-CPP Boehringer to the incubation mix-
ture.
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In another series of control experiments, incuba-
tions were done in a physiological buffer with mil-
 .limolar concentrations of inorganic phosphate P toi
compete with labeled 32P , which can be derivedi
w 32 xfrom hydrolyzed g- P ATP. Indeed, ecto-ATPases
– which we have shown to be present in lymphocytes
w x w 32 x3 – can hydrolyze g- P ATP, and the resulting
32P could then pass through the cell membrane lead-i
ing to phosphorylation of intracellular proteins, which,
in turn, could be misinterpreted as being due to
ectophosphorylation. As would be expected if phos-
phorylating enzymes did indeed utilize extracellular
ATP, the presence of high concentrations of inor-
ganic phosphate did not affect phosphorylation data
.not shown .
2.4. Trypsin treatment
Before labeling, cells were treated for 3 min with 5
 .mgrml trypsin Worthington, Freehold, NJ at 378C.
Trypsinization was stopped by adding 30 mgrml
trypsin inhibitor to the cell suspensions. Cells were
 .washed and centrifuged 5 min, 1200 rpm, 240=g ,
checked for viability, and taken into the ectophospho-
rylation assay as described above. Trypsinization did
not affect viability of cells as measured by Trypan
 .blue exclusion data not shown .
2.5. Measurement of cation dependency of
ectophosphorylation
Cells were resuspended in Ca2q- and Mg2q-free
HBSS, 10 mM HEPES, 10 mM glucose, pH 7.4. To
measure the Ca2q and Mg2q dependency of the
ectophosphorylation, cations were added to the reac-
tion mixture at a final concentration of 1.0 mM. The
ectophosphorylation assay was carried out as de-
scribed above. In other experiments, MgCl , and2
MnCl were added to achieve the concentrations2
indicated in the figures.
2.6. Detection of ecto-ATPrGTP-binding sites
Labeling of ATPrGTP-binding sites of extracellu-
lar portions of membrane proteins was done using a
modified procedure originally described by Peter et
w xal. 10 . Cells were isolated over FicollrHypaque and
washed with HBSS 10 mM HEPES, 10 mM MgCl ,2
 6.pH 7.4. Cells 2=10 were then resuspended in 0.5
w 32 x wml and incubated with 10 mCi a- P ATP or a-
32 x  .P GTP final ATPrGTP conc. 16.6 nM for 10 min
at 378C. To crosslink ATP or GTP to the binding site
of the protein, ribose moiety was oxidized by incuba-
tion with 1 mM NaIO for 1 min on ice and subse-4
quently reduced with 1 mM NaCNBH during the 13
min on ice. The reaction was stopped by addition of
20 mM NaBH and incubation for 5 min on ice.4
Cells were centrifuged for 5 min at 1200 rpm 240=
.g and lysed in 50 ml SDS sample buffer. Proteins
were run on SDS–PAGE and analyzed by auto-
radiography. To detect intracellular ATPrGTP-bind-
ing sites prior to labeling, cells were permeabilized
with 10 mgrml lysophosphatidylcholine in permeabi-
lization buffer 20 mM HEPES, 140 mM KCl, 10
.mM NaCl, 2.5 mM MgCl , pH 7.8 for 5 min. Cells2
were washed and resuspended in HBSSrHEPESr
MgCl .2
2.7. Inhibitors and acti˝ators of ectophosphorylation
To inhibit ectokinase activity, intact cells were
incubated in the presence of various protein kinase
 .inhibitors. Staurosporine Gibco-BRL was dissolved
in DMSO and added to a final concentration of 5
mM. Heparin from porcine intestinal mucosa Sigma,
.  .cat. no. H3393 , a specific casein kinase II CKII
w xinhibitor 11 , was dissolved in reaction buffer and
used at concentrations as indicated in the figures.
 .  .Dichlorobenzoimidazole furanoside DCBF Sigma ,
w xanother specific inhibitor of CKII, but also CKI 12 ,
was dissolved in a reaction buffer and used at a final
concentration of 100 mM.
To measure the activation of the ectokinase activ-
 . w xity, spermine Sigma , an activator of CKII 13 , was
added to the samples at a final concentration as
indicated in the figures. All these reagents were
shown not to affect viability of the cells data not
.shown .
2.8. Phosphorylation of exogenous substrates
For detection of phosphorylation of exogenous
 .substrates, casein Sigma at a concentration of 1
mgrml was added to cell suspensions in reaction
buffer. Casein was used as a substrate in most experi-
ments described here after preliminary experiments
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established the preferential ectophosphorylation of
casein by ectokinases. Phosphorylation of casein was
w 32 x started by the addition of 10 mCi g- P ATP final
.ATP conc. 16.6 nM , and the mixture was incubated
for 10 min at 48C or 378C. Following incubation,
 .cells were centrifuged 5 min, 1200 rpm, 240=g ,
and part of the supernatant was mixed with 5H SDS
sample buffer. Samples were analyzed by SDS–
PAGE using 10–20% gradient gels as described
above. After the gels were stained, destained, and
dried, the protein bands corresponding to casein were
cut out and counted in a scintillation counter Beck-
.man, Columbia, MD . As a control for non-specific
binding of radiolabel by the substrate, casein was
w 32 xincubated with g- P ATP in the absence of cells.
2.9. Ectophosphorylation of CKII specific peptide
A casein kinase II assay Upstate Biotechnology,
.Lake Placid, NY was used to measure specific ectok-
 5inase activity on 2B4 cells. Briefly, 2B4 cells 10
.cells were incubated in HBSS buffer containing 10
mM MOPS, 12.5 mM glycerol phosphate, 2.5 mM
EGTA, 0.5 mM Na- orthovanadate, 0.5 mM DTT,
0.25 mM casein kinase II specific peptide RRRDD-
.DSDDD , 20 mM MgCl , 125 mM cold ATP, and 102
w 32 xmCi g- P ATP for 20 min at 378C. After the incu-
bation, cells were centrifuged for 10 min at 1000 rpm
 .180=g and 20 ml was spotted on phosphocellulose
paper. The phosphocellulose paper was washed 5
 .times in cold 1% vrv phosphoric acid solution and
2 times with H O. The phosphocellulose paper was2
subsequently counted in a scintillation counter Beck-
.man, Columbia, MD .
2.10. 32P labeling of cells in the presence andi
absence of K-252a and K-252b kinase inhibitors
 6 .One million cells 5.0=10 cellrml were incu-
bated for 30 min at 378C with 10 mCi of 32P in 200i
ml of phosphate-free RPMI 1640 media Biofluids,
. Inc. supplemented with 10% vrv, dialyzed 3 times
.against phosphate-free RPMI 1640 fetal calf serum.
Cell labeling was performed in the presence or ab-
sence of water-soluble and -insoluble kinase in-
hibitors at concentrations indicated in the figure leg-
ends. K-252a and K-252b protein kinase inhibitors
 .were purchased from Kamiya Thousand Oaks, CA .
Cells were washed twice with HBSS containing 10
mM MgCl and preincubated for 1 h in phosphate-2
 .free RPMI 1640 media Biofluids, Inc. prior to
labeling in a CO incubator. After labeling, the reac-2
tion mixtures were centrifuged 1000 rpm, 10 min,
.180=g and the supernatant removed; the cells were
washed with 200 ml phosphate-free media, then lysed
 .with 0.5% vrv NP-40 and analyzed by SDS–PAGE
and autoradiography.
2.11. Cytotoxicity assay
51  .Cr-labeled target cells P-815 were resuspended
in assay buffer consisting of DMEM supplemented
Fig. 1. Demonstration of ectophosphorylation of lymphocytes.
w 32 x 32CTL-OE4 lymphocytes were incubated with g- P ATP or Pi
or
32PP for 10 min according to the standard ectophosphoryla-i
tion assay described in Section 2: Experimental procedures. To
ensure that phosphorylation of extracellular portions of surface
proteins was detected, the following control experiments were
performed. A: lanes 1 and 2, CTL-OE4 were incubated with 10
w 32 xmCi g- P ATP for 10 min at 37 and 48C, respectively; lanes 3
and 4, incubation with 10 mCi 32P or 10 mCi 32PP , correspond-i i
w 32 xingly, for 10 min at 378C; lane 5, 10 mCi g- P ATP and 10
w 32 xmM EDTA; lane 6, 10 mCi g- P ATP and 80 Urml hexoki-
w 32 xnase; lane 7, 10 mCi g- P ATP and 100 Urml apyrase;
representative example from 3 to 4 experiments.
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with 5% FCS and 5 mM HEPES. To promote cell-
51  4mediated lysis, Cr-labeled target cells 10
.cellsrwell were mixed with CTL at different effec-
 . w xtor : target E:T ratios as previously described 5 in
triplicate in 96-well, V-bottom plates. After incuba-
tion, the 96-well plate was centrifuged 5 min, 800
.rpm , and 50 ml of the supernatants were harvested.
Radioactivity in the samples was counted using a
Beckman gamma counter Beckman Instruments, Inc.,
.Fullerton, CA , and the mean value of each triplicate
was determined. The percentage of specific 51Cr re-
 .  .lease was calculated as 100= ayb r tyb , where
a is 51Cr release from target cells in the presence of
CTL, b is spontaneous release from labeled target
cells in the absence of CTL, and t is the total number
of cpm in the target cells. Spontaneous 51Cr release
from target cells was in the range of 10–15% of the
total cpm.
3. Results
3.1. Ectophosphorylation of extracellular domains of
cell membrane proteins
 .  .Incubation of intact T-cells CTL-OE4 Fig. 1
w 32 xwith membrane impermeable g- P ATP at 16.6 nM
readily resulted in a temperature-dependent and
time-dependent phosphorylation of cell membrane
 .proteins e.g., Fig. 1, lanes 1 and 2 . Similarly,
cytotoxic T-cell hybridomas PN37, MD45, MD90,
.and MD45-27J , T-helper hybridoma 2B4, T-cell thy-
Fig. 2. Ectolabeling of lymphocytes is due to covalent binding of phosphate and can be inhibited by inclusion of cold AMP-CPP or
w 32 xremoval of ectoproteins by trypsin pretreatment. 2B4 lymphocytes were incubated with 10 mCi g- P ATP for 10 min according to the
standard ectophosphorylation assay described in Section 2: Experimental procedures. A: inhibition of 2B4 phosphorylation in the presence
 .  .of ATP analog AMP-CPP 100 mM lane 3 . B: effect of trypsin treatment on the phosphoprotein pattern in 2B4 cells. Cells were
pretreated with trypsin as described in Section 2. Pretreated cells or control cells were subsequently incubated for 10 min at 378C with 10
w 32 x w 32 x  . w 32 x w 32 xmCi g- P ATP. Lane 1, control; lane 2, trypsin pretreatment. C: both g- P GTP lane 1 and g- P ATP, but not a- P ATP can
serve as phosphate donors in ectophosphorylation of 2B4. Cells were incubated for 10 min at 378C in the presence of 10 mCi of the
indicated nucleotide. Data are representative examples from 3 experiments.
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moma EL-4, and freshly isolated PELs, as well as
P-815 mastocytoma cells, all had many easily de-
tectable, ectophosphorylated surface proteins ranging
in molecular weight from 14 to 200 kDa. Both quan-
titative and qualitative differences were observed in
the ectophosphorylation patterns of these cells data
.not shown .
In order to prove the ‘ecto’ nature of the phospho-
w 32 xrylation after incubation with g- P ATP, we per-
formed extensive control experiments. Intracellular
w 32 xlabeling of proteins due to hydrolysis of g- P ATP
and intracellular formation of 32P-labeled ATP was
prevented by using millimolar concentrations of inor-
 .ganic phosphate P in the standard ectophosphoryla-i
tion incubation. In addition, millimolar concentra-
tions of unlabeled ATP present intracellularly will
also compete with the labeling of intracellular pro-
teins. Indeed, no labeling of cell proteins occurred
when 32P or 32PP was added to cell suspensionsi i
 .Fig. 1, lanes 3 and 4 during a 10-min incubation
period. This excludes the possibility of phosphoryla-
tion of intracellular proteins by 32P or 32PP possiblyi i
wformed through the hydrolysis of extracellular g-
32 xP ATP.
Furthermore, the labeling is not the result of strong
ATP binding and is, indeed, due to phosphorylation
w 32 x wsince, when a- P ATP was used instead of g-
32 xP ATP, no labeling of any protein was observed
 .Fig. 2C, lane 3 , reflecting that only transfer of
g-phosphate to ectosubstrates is detected under our
assay conditions.
Phosphorylation by ectokinases is expected to be
inhibitable by the presence of ATP-consuming en-
zymes, whereas intracellular phosphorylation should
not be affected. This was indeed the case, since we
observed inhibition of labeling of proteins by ATPo
in the presence of hexokinase or apyrase Fig. 1,
. lanes 6 and 7 the only labeled band in lane 6 is due
.to autophosphorylation of hexokinase itself .
Labeling of ectosubstrates was strongly inhibited
by water-soluble, cell-impermeable ATP analog,
AMP-CPP, a hydrolyzable ATP analog, most likely
w 32 xdue to competition with g- P ATP for binding at
 .the ATP-binding sites of ectokinase s and phospho-
 .rylation Fig. 2A .
Additional evidence that the observed phosphory-
lation of most of labeled proteins is due to phospho-
rylation of extracellular portions of surface proteins
was provided by the use of proteases to remove
 .cell-surface proteins Fig. 2B . Treatment with trypsin
w 32 xprior to incubation with g- P ATP substantially
reduced ectophosphorylation of cells either due to the
removal of ectoprotein kinases or their ectosubstrates.
Fig. 3. Labeling of the extracellular ATP- and GTP-binding
proteins on lymphocyte surface. Lanes 1–3: labeling of ATP-bi-
wnding proteins in 2B4 cells. Cells were incubated with a-
32 xP ATP for 10 min at 378C, followed by covalent linkage of the
 .nucleotide to its binding site through periodate oxidation lane 1 ,
as described in Section 2: Experimental procedures. Competition
for labeling of ATP-binding site which reflects the specificity of
. interactions was studied by inclusion of 100 mM cold ATP lane
.  .2 or GTP lane 3 . Lanes 4–6: labeling of GTP-binding proteins
w 32 xin 2B4 cells. Cells were incubated with a- P GTP for 10 min
at 378C, followed by covalent linkage of the nucleotide to its
 .binding site through periodate oxidation lane 4 ; lanes 5 and 6,
 .effect of inclusion of 100 mM cold ATP lane 5 or 100 mM cold
 .GTP lane 6 on labeling of GTP binding sites; lanes 7 and 8,
labeling of lysophosphatidyl choline-permeabilized 2B4 cells with
w 32 x  . w 32 x  .a- P ATP lane 7 or a- P GTP lane 8 . Data are represen-
tative examples from 4 to 5 experiments.
( )F.A. Redegeld et al.rBiochimica et Biophysica Acta 1328 1997 151–165158
3.2. ATP- and GTP-binding sites at the cell surface
Important evidence for the presence of ectoen-
zymes in lymphocytes is provided by the demonstra-
tion of ATP-binding proteins and GTP-binding pro-
teins by labeling of extracellular ATP- and GTP-bi-
 .nding sites Fig. 3 on the surface of T-cells. These
ATP-binding proteins are expected to include ectoki-
nases, ecto-ATPases, and purinergic ATP receptors.
Their expression is demonstrated here using chemical
w 32 x w xcrosslinking of a- P ATP 10 . More than 20 major
wcell-surface proteins of 2B4 were labeled with a-
32 x  .P ATP Fig. 3, lane 1 . Labeling was specific for
ATP, since an excess of cold ATP reduced incorpora-
tion of label by approximately 35% e.g., radiolabel-
.ing of 25 kDa protein , whereas cold GTP did not
 . w 32 xFig. 3, lanes 2 and 3 . Labeling with a- P GTP
revealed GTP-binding proteins on the cell surface of
 .2B4 cells. Excess cold GTP lane 6 , but not ATP
 .lane 5 inhibited the incorporation of label, showing
the specificity of the labeling. A 56% inhibition of
labeling of radiolabeled 50 kDa protein in presence
of cold GTP was observed, whereas cold ATP re-
duced labeling only by 8%. The pattern of GTP-
labeled proteins is different from that after ATP
labeling. Prominent GTP-labeled proteins have
molecular weights of approximately 50, 27, and 24
kDa.
Control labeling of intracellular ATPrGTP-bind-
ing sites in permeabilized cells resulted in a com-
pletely different labeling pattern Fig. 3, lanes 7 and
.8 when compared to labeling of intact cells. Most
notably, among the intracellular proteins that were
extensively labeled in permeabilized cells, but were
not detected amongst ectolabeled proteins, are at least
five proteins, with molecular weights ranging from
90 to 200 kDa. Since we loaded approximately ten
times less protein obtained from the permeabilized
cells on the gels, the specific ATP-labeling of these
intracellular proteins is much higher than that of the
extracellular portions of proteins from intact cells.
Similar results were obtained with the CTL clone
Fig. 4. Cation dependency of ectophosphorylation. A: effect of different combinations of Ca2q and Mg2q on ectophosphorylation of 2B4
 . 2qcells at 4 and 378C. Arrows 1, 2, and 3 next to lane 4 at 4 and 378C indicate proteins that are ectophosphorylated in a Ca - and
Mg2q-independent manner. B: Mn2q and Mg2q concentration dependency of the ectophosphorylation of CTL OE4; lanes 1–5, effect of
2q 2q  .increasing concentrations Mg on phosphorylation, lane 6 and 7, effect of increasing concentrations of Mn mM on ectophosphoryla-
w 32 xtion of 2B4. Incubation was performed in the presence of 10 mCi g- P ATP for 10 min at 378C. Data are representative examples from
3 to 4 experiments.
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 .OE4 data not shown . The extensive qualitative and
quantitative differences between intact and permeabi-
lized cells suggest that the observed labeling is in-
deed due to the presence of ATP-binding sites of
proteins that are exposed on the extracellular side of
the plasma membrane of the lymphocyte.
3.3. Characterization of ectoprotein kinase on T-cells:
cation dependency of ectophosphorylation
Extracellular phosphorylation of T-cells was Mg2q
 .dependent Fig. 4 and increasing the concentration
of Mg2q augmented the labeling. Addition of Ca2q
to the medium not only did not increase ectophospho-
rylation, but the labeling of some proteins was dimin-
ished compare labeling pattern form lane 1 with lane
.2 in Fig. 4A . This indicated the presence of specific,
but minor, Ca2q-dependent ectophosphatase activity
and, possibly, specific phosphorylationrdephospho-
rylation of some ectophosphoproteins.
The addition of EDTA to chelate Mg2q and Ca2q
resulted in a greatly decreased phosphorylation of
most proteins in a short-term ectophosphorylation
assay. Of special interest are two ectophosphorylated
proteins, with apparent MW of 38 and 43 kDa, which
were extensively labeled even in the presence of
 .EDTA Fig. 1, lane 5 . Labeled proteins with similar
molecular weights were prominent after incubation in
2q the absence of Ca Fig. 4A; compare bands marked
.by arrows in lanes 3 and 4 , indicating that these
proteins are phosphorylated in a Ca2q- and Mg2q-in-
dependent manner. The nature of these phosphopro-
teins is not yet known and warrants further investiga-
tion.
Addition of Mn2q greatly enhanced ectophospho-
 . 2qrylation Fig. 4B . Interestingly, Mn has an in-
hibitory effect on CTL function, possibly due to
interference with a Ca2q-dependent step, but not due
w xto inhibition of the CTL–target cell adhesion 5 . Our
observation of strong Mn2q dependency of ectoki-
nase activity is in agreement with the observation of
w xSkubitz et al. 20 , in neutrophils, but is in contrast to
w x 2qKinzel et al. 24 , who found that Mn inhibited the
activity of ectokinase of HeLa cells. It remains to be
established if the observed effect of Mn2q is also
linked to ectotyrosine kinase activity, since similar
enhancing effects of Mn2q were observed with ecto-
protein tyrosine kinase activity in epidermoid cells
w x19 .
3.4. Ectokinase has properties of a casein kinase II
( )CKII
The results of preliminary experiments data not
.shown , in which different substrates and inhibitors
were tested in ectophosphorylation assays, suggested
that one of the major ectokinases in T-lymphocytes is
Fig. 5. Effect of different protein kinase inhibitors on phosphory-
lation of surface proteins of T-cells. A: effect of heparin, stau-
 .rosporine, and 5,6-dichlorobenzimidazole furanoside DCBF on
the ectophosphorylation of surface proteins of 2B4 cells. Cells
were incubated for 10 min at 378C in presence of 10 mCi
w 32 xg- P ATP. Left panel: lane 1, ectophosphorylation of 2B4
cells, no heparin present; lanes 2, 3, 4, and 5, ectophosphoryla-
tion of 2B4 in the presence of 5, 10, 50, and 100 mgrml heparin,
respectively. Right panel: lane 1, ectophosphorylation of 2B4
cells for 10 min at 378C, no inhibitors present; lane 2, 10 mM
staurosporine; lane 3, 100 mM DCBF. Data are representative
examples from 2 to 3 experiments.
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similar to CKII. A broad-spectrum protein kinase
inhibitor, staurosporine, inhibited total ectophospho-
rylation at a relatively low concentration for 36%
 .Fig. 5B, lane 2 . Other inhibitors, such as heparin
 .and 5,6-dichlorobenzimidazole furanoside DCBF
 .Fig. 5B, lane 3 , both inhibitors of CKII activity
w x11,12 , have also been shown to be very effective
 .blockers of ectophosphorylation. DCBF 100 mM
reduced the total incorporated label for 35%. Heparin
caused a concentration-dependent inhibition of ec-
tophosphorylation, and as little as 5 mgrml of hep-
 .arin Fig. 5A, lane 2, left panel was sufficient to
effectively decrease the incorporated label into cell
membrane proteins of 2B4 cells. Total ectophospho-
rylation of 2B4 was reduced by 45% at 100 mgrml
heparin. In addition, the recently developed inhibitor
of ectoprotein kinases, the membrane-impermeable
w xcompound K-252b 26,27 , strongly inhibited ec-
tophosphorylation in our assays, while having no
 .effect on intracellular phosphorylation see Fig. 8 .
Phosphorylation of the exogenously added protein
substrate casein was inhibited by heparin in a dose-
 .dependent fashion Fig. 6A at both 4 and 378C. At 5
mgrml, heparin inhibited casein phosphorylation
more than 60%. At 48C, the intracellular uptake of
heparin by active mechanisms is very unlikely, pro-
viding strong support for the inhibitory effect on an
 .extracellular process Fig. 6A . Other sulfated poly-
 .saccharides e.g., dermatan sulfate, hyaluronic acid
were much less inhibitory or not at all effective in
blocking phosphorylation of either exogenous or en-
dogenous ectosubstrates in accordance with their CKII
w x  .inhibitory potency 13 data not shown .
 .Addition of cAMP or cGMP 0.5 mM into the
ectokinase assay of T-cells did not influence the
degree or pattern of phosphorylation of the mem-
 .brane proteins data not shown , suggesting that, in
w xcontrast to other cells 28 , no cAMP- or cGMP-de-
pendent ectoprotein kinases are present at the T-cell
surface.
Our data suggested that one of the most active
ectoprotein kinases on the T-cell surface has similari-
ties to CKII. A similar kinase has been reported to be
present on the surface of other cell types, including
Fig. 6. Heparin inhibits and spermine enhances the phosphorylation of extracellular casein by 2B4 lymphocytes. A: effect of heparin on
 .the phosphorylation of casein. Substrate casein was added to intact 2B4 cells at 4 and 378C and incubated for 10 min after addition of 10
w 32 x  .mCi g- P ATP in absence or presence of increasing concentrations of heparin 0, 5, 10, 50, and 100 mgrml . After the incubation,
supernatant was collected, subjected to SDS–PAGE and radioactivity of the casein bands was quantitated. B: effect of casein kinase II
 .  .activator, spermine 0, 5, 1.0, and 2.0 mM on the ectophosphorylation of casein by 2B4. Substrate casein was added to intact 2B4 cells
w 32 xat 378C and incubated for 10 min after addition of 10 mCi g- P ATP in the presence of increasing concentrations of spermine. Data are
representative examples from 3 to 4 experiments.
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Table 1
Phosphorylation of casein kinase II specific peptide by intact 2B4
lymphocytes
a,bIncorporated label
2B4qCKII peptide 5048"101
c2B4qCKII peptideq1 mM cold ATP 1360"249
c2B4qCKII peptideq1 mM cold GTP 696"264
a Corrected for no peptide addition.
b Results represent mean from 3 separate experiments with 4
replicates.
c Significantly different from 2B4qCKII peptide, P -0.05.
w xneutrophils and HeLa cells 21 . One of the identify-
ing properties of CKII-like kinases is their ability to
efficiently use both ATP and GTP as phosphate
w xdonors 13 . In agreement with the identification as
CKII-like protein kinase, the ectokinases from 2B4
 .and OE4 are shown here Fig. 2C, lanes 1 and 2 to
w 32 x w 32 xutilize both g- P GTP and g- P ATP equally well.
Another property of CKII protein kinase is that
polycations such as spermine can stimulate kinase
w xactivity 13,14 . An increase of up to four times in the
phosphorylation of casein by 2B4 cells was observed
 .in the presence of 0.5 mM spermine Fig. 6B .
Similarly, spermine enhanced phosphorylation of ca-
sein by CTL-OE4. No effect of spermine on cell
viability was observed, thus excluding the possibility
of the increased kinase activity being caused by
leakage of intracellular protein kinases data not
.shown . Furthermore, a specific peptide substrate for
CKII protein kinase is rapidly phosphorylated by
 .intact 2B4 lymphocytes Table 1 . Phosphorylation of
the peptide is inhibited by adding both cold ATP or
 .GTP 1 mM . Thus, these results suggest that T-cells
express at least one protein kinase with casein kinase
II-like properties.
3.5. Substrate specificity of the ectoprotein kinase in
phosphorylation of serum proteins
The exact physiological role of ectokinases in
T-cells is not clear, but clues may come from the
identification of specific substrates of ectokinases.
Cell surface-located ectoprotein kinases that can
phosphorylate endogenous cell-surface proteins or
 .exogenous substrates e.g., fibroblast growth factor
w x14 , when submicromolar concentrations of extracel-
lular ATP are present, have been detected in different
w xintact cells 14–19 . An important serum protein vit-
ronectin was shown to be a specific substrate for
w xhuman neutrophil ectoprotein kinase 20 .
A comparison of phosphorylation of purified vit-
ronectin and fibronectin was done in experiments
where T-cells were incubated with these protein sub-
w -32 x  .strates in the presence of g P ATP. Results Fig. 7
reveal the remarkable substrate specificity of the
 .ectokinase for vitronectin lanes 1–3 , but not for
Fig. 7. Substrate specificity of ectoprotein kinase. Vitronectin,
but not fibronectin, is a substrate for phosphorylation by the
T-cell surface ectoprotein kinases. Intact cells were incubated
w -32 x  .with g P ATP in presence of vitronectin 50 mgrml or
 .fibronectin 100 mgrml for 10 min at 378C as described in
Section 2: Experimental procedures. The cells were centrifuged
 .after incubation, and cell-associated proteins cell pellet, lane 1
and supernatants were analyzed for the composition of phospho-
rylated proteins. Lane 1, CTL-OE4 cell pellet-associated proteins.
 .Vitronectin chains 85 and 72 kDa are indicated by arrows; lane
2, phosphorylated chains of vitronectin in supernatant of CTL-
OE4. Arrows indicate the positions of the 85- and 72-kDa
vitronectin chains; lane 3, incubation of vitronectin with
w -32 xg P ATP in the absence of cells; lanes 5–7, no detectable
phosphorylation of fibronectin by T-cells; lane 5, CTL-OE4 cell
pellet-associated proteins; lane 6, phosphorylated proteins in cell
supernatants after incubation with fibronectin; lane 7, incubation
of fibronectin in the absence of cells. Arrow indicates position of
220-kDa fibronectin band on protein-stained gel. Data are repre-
sentative examples from 3 experiments.
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Fig. 8. Effect of cell membrane-impermeable ectoprotein kinase inhibitor K-252b on T-cell ectophosphorylation and effector functions.
Comparison of effects of K-252a and K-252b on ecto- and intracellular protein phosphorylation of CTL-OE4. A: both K-252a and
K-252b inhibit extracellular phosphorylation. Ectophosphorylation assay of intact CTL-OE4 cells was performed in the presence of
 .  .increasing concentrations of cell-permeable kinase inhibitor K-252a upper panel or the cell-impermeable inhibitor K-252b lower panel
as described in Section 2: Experimental procedures. B: K-252a, but not K-252b, is efficient in the inhibition of intracellular
32  .phosphorylation. CTL-OE4 cells were metabolically labeled with P for 30 min at 378C see Section 2 in the presence of increasingi
 .  .concentrations of cell-permeable kinase inhibitor K-252a upper panel or the cell-impermeable inhibitor K-252b lower panel . C:
 .  .  .densitometer analysis of the inhibitory effect of K-252a open symbols and K-252b closed symbols on extracellular left figure and
 . intracellular middle figure phosphorylation of CTL-OE4. Arrows identify arbitrarily chosen protein bands indicated by arrows in A and
.B , that are compared using a computerized densitometer. Right figure, K-252b inhibits CTL cytotoxicity at concentrations, which
effectively block extracellular phosphorylation, but not intracellular phosphorylation. CTL-OE4 were incubated with 51Cr-labeled
allogeneic target cells P-815 at different effector to target ratios for 4 h at 378C. The cell impermeable kinase inhibitor K-252b was added
to the incubation at increasing concentrations. After 4 h, target cell death was measured by determining the 51Cr release in the
supernatant, as described in Section 2. Data are representative examples from 2 experiments.
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 .fibronectin lanes 5–7 , since phosphorylated chains
 .of vitronectin 85 and 72 kDa are observed both
 .cell-associated lane 1 and in supernatants after incu-
 .bation with OE4 lanes 2 . Both vitronectin and
fibronectin were present in the assay as evidenced by
 .protein staining of gels data not shown . No phos-
phorylation of vitronectin was observed when incuba-
w 32 xtion with g- P ATP was performed in the absence
 .of cells lanes 3 and 7 .
3.6. Correlations of inhibition of ectokinase and
cellular cytotoxicity by general and CKII-specific
protein kinase inhibitors
Important evidence supporting the role of ec-
tophosphorylation in T-cell effector functions was
provided by experiments where the water-soluble and
w xmembrane-impermeable inhibitor K-252b 21,22 was
able to inhibit CTL cytotoxicity Fig. 8C, right fig-
.ure . This ability to interfere with functions of intact
cells without entering the cell interior is interpreted
as evidence for the involvement of ectoprotein ki-
nases.
We confirmed the ability of this inhibitor to affect
ectophosphorylation of T-lymphocytes but not intra-
.cellular phosphorylation in our experimental system
 . Fig. 8 . Both K-252a membrane-permeable, chemi-
.cally closely related protein kinase inhibitor and
K-252b were able to inhibit ectophosphorylation Fig.
.8A, lower panel at concentrations similar to those
described in ectophosphorylation studies using neu-
w xronal cells 33 . As predicted, K-252b was indeed
unable to block intracellular protein phosphorylation
32  .using P Fig. 8B, lower panel .i
Strong inhibition of CTL-mediated cytotoxicity by
cell membrane-impermeable ectokinase inhibitors K-
 .252b Fig. 8, right figure was observed at concentra-
tions that correlate with the ability of K-252b to
block ectophosphorylation without interference in in-
 .tracellular phosphorylation Fig. 8C, left figure . This
inhibition is likely to be exerted on the level of the
cell–cell contacts since, e.g., 5 mM K-252b strongly
inhibited CTL-mediated cytotoxicity during cell–cell
interactions, while no effect of 5 mM K-252b on
anti-TCR mAb-induced granule exocytosis from CTL
 .was detected data not shown .
In addition to the recently developed inhibitor of
ectokinases K-252b, we tested other available in-
hibitors of CKII-kinase. Target cell lysis induced by
CTL-OE4 was also inhibited by various inhibitors of
CKII protein kinase. Heparin at 100 mgrml strongly
inhibited ectophosphorylation and inhibited CTL-in-
duced TC lysis. Importantly, highly inhibitory con-
centrations of heparin in cytotoxicity assays against
nucleated TC did not affect lysis of sheep red blood
cells at all. These data serve as an important control
that heparin is not interfering in the TCR-triggered
transmembrane activation of CTL, but inhibiting in-
teractions leading to nucleated TC lysis. Inclusion of
other mucopolysaccharides, such as hyaluronic acid
or dermatan sulfate, which do not have a strong
w xinhibitory effect on CKII activity 11 , did not have a
significant effect on OE4-induced TC lysis. Polyanet-
 .hole sulfonate PSA , a highly charged anion that was
shown to block cell-mediated killing as reported ear-
w xlier 23 , also blocked retargeted killing of EL-4 by
CTL-OE4. PSA was used here, since it was found to
be a potent inhibitor of the ectoprotein kinase activity
w x12 . Another inhibitor of CKII, DCBF, at 100 mM
caused strong inhibition of the TC lysis by CTL-OE4.
Addition of casein, acting as a competitive substrate
for phosphorylation by CKII, resulted in a nearly
complete inhibition of TC lysis at 5 mgrml data not
.shown .
4. Discussion
Our present working hypothesis is based on the
assumption that after TCR-triggered accumulation of
 2y 4y.ATPo as MgATP but not ATP on the surface
of the T-cell, the lymphocyte’s ectoprotein
kinasesrphosphatases could phosphorylaterdephos-
phorylate extracellular portions of plasma membrane
proteins including recognition molecules, growth
factor receptors, growth factors, and cell–cell adhe-
.sion proteins , changing their conformation, affinity
to ligands, ability to propagate transmembrane sig-
nals, and capacity to form multimolecular complexes.
Such changes may play a role in the regulation of
molecular interactions during cell–cell contacts be-
tween, e.g., CTL and target cells, T-helper and APC,
w xand T-helper and B-cells 7 .
In this study, we show the presence of ectoprotein
kinase activity on the surface of murine T-lympho-
cytes. Several cell-surface proteins of the T-cells are
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phosphorylated in the presence of ATPo. Extensive
w xcontrol studies 24 confirmed that labeling was due
to ectophosphorylation and was not the result of
labeling of proteins by intracellular protein kinases
w 32 xdue to uptake of hydrolyzed g- P ATP. Since in
our experiments we used nanomolar concentrations
 .of ATP final conc. 16.6 nM and reported plasma
concentrations of ATP range from 200 to 1150 nM
w x25 , ectophosphorylation in vivo likely to occur.
Further characterization of the ectoprotein activity
revealed properties of a CKII-like kinase, which
phosphorylation activity could be supported by both
ATP and GTP as phosphate donor and could be
inhibited by classical CKII inhibitors as heparin,
DCBF or enhanced by spermine. Recently, the pres-
ence of a heparin-inhibitable CKII-like ectoprotein
kinase has also been described for human neutrophils
w x20 .
The potential role of these ectoprotein kinase activ-
ity in the effector function of the lymphocytes was
examined using the hydrophilic protein kinase in-
w xhibitor K-252b 26 . Ehrlich and collaborators found
that K-252b inhibited nerve growth factor-induced
neurite outgrowth in PC12 cells, which was mediated
through the inhibition of ectoprotein kinase activity
w x27 . Previous studies showed that K-252b does not
w xpermeate the cell membrane 21,22 , although some
w xcontroversy exists about the impermeability 36 . Our
study showed that K-252b at concentrations which
greatly inhibited extracellular phosphorylation, was a
potent inhibitor of the killing of P-815 TC by CTL-
OE4 in a cytotoxicity assay. Since K-252b did not
affect intracellular phosphorylation at these concen-
trations, interference with intracellular events is not
likely to be the cause of inhibition of CTL effector
function. Moreover, similar results were obtained
using heparin, DCBF, other ectoprotein kinase in-
hibitors or by the inclusion of casein as a competitive
substrate for the ectoprotein kinases unpublished
.results . These results strongly suggest the impor-
tance of the ectoprotein kinase activity in the effector
function of CTL.
The mechanism by which ectophosphorylation of
cell-surface proteins is involved in modulating the
effector function of T-cells is presently unknown.
Firstly, the possibility is considered that ectodomains
of important surface proteins could be phosphory-
lated while inside cells and subsequently be dephos-
phorylated by ectoprotein phosphatases. Indeed, since
many secretory proteins are SerrThr-phosphorylated
w x28 , it was proposed that ectoprotein kinases can
phosphorylate secreted proteins during their presence
w xin the lumen of ER or Golgi complex 29 before the
ectoprotein kinase is transported to the cell surface.
Recently, we have found that ectodomains domains
of the T-cell antigen receptor is constitutively phos-
phorylated at serine and threonine intracellularly. In
addition, phosphorylation of the extracellular do-
mains could also be achieved by extracellular ATP,
suggesting that ectophosphorylation of T-cell recep-
tor domains can reversibly modified by extracelluar
w xprotein phosphatases and kinases 30 . Secondly, it is
also possible that – by autophosphorylation or phos-
 .phorylation of neighboring cell-surface proteins –
the ectoprotein kinase transduces transmembrane sig-
nals. This is evidenced by the observation of changes
in activity of PC-1, a threonine-specific ectoprotein
kinase present on plasma cells, in response to fibrob-
 . w xlast growth factor FGF 29 . Thirdly, ATPo may
also modulate the functioning of recognition andror
adhesion molecules by phosphorylating their cyto-
plasmic domains. This is supported by the demonstra-
tion that ATPo mediated the phosphorylation of
CD31, CDw32, and HLA-class I proteins on the
w xsurface of human neutrophils 31 . Lastly, phosphory-
lationrdephosphorylation of ectoproteins can have
substantial effects on their binding affinity for other
proteins. For instance, phosphorylation of the
ectodomains of CD36, a membrane receptor of
thrombospondin, malaria-infected erythrocytes and
collagen, increased its affinity for collagen and re-
sulted in a loss of trombospondin binding. Whereas,
dephosphorylation of CD36 induced opposite binding
w xreactivity towards these substrates 32 . Our study
shows that CTL-OE4 and 2B4 lymphocytes exhibit a
clear substrate specificity, mediating the phosphoryla-
tion of the serum protein vitronectin, but not fi-
bronectin. It is presently unknown if phosphorylation
of vitronectin modulates its ability to bind to its
receptor. It is interesting to note that we have also
found the presence of ectoprotein phosphatase activ-
ity on the lymphocyte’s cell surface unpublished
.results , indicating that there is a complete system of
phosphorylation and dephosphorylation present at the
cell surface.
According to ongoing studies, ATPo may, in addi-
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tion, act by transmitting transmembrane signals
w xthrough purinergic receptors 33 . Effects of ATPo on
the thymocyte development in the fetal thymus organ
culture are consistent with a role for the p2x ATPo
w xreceptor in thymocyte maturation 8 . The recent
discovery of identity between the p2x ATPo puriner-
w xgic receptor 34 and the thymocyte apoptosis related
w xRP2 gene 35 suggests a functional importance of
these receptors in T-cell development. Moreover, we
recently cloned a p2u ATPo receptor from a T-
lymphocyte’s cDNA library and we are currently
investigating the functional role of this purinergic
receptor M. Koshiba, S. Apasov, and M.V.
.Sitkovsky, manuscript in preparation .
In conclusion, the results described here point to
the presence of a functional ectophosphorylation sys-
tem on the lymphocyte surface. Phosphorylation and
possibly dephosphorylation of ectosubstrates may be
important in the regulation of cell–cell interactions.
Since cell–cell interactions are of decisive impor-
tance in the functioning of the immune system, our
experiments point to the need to study specific ec-
tophosphorylated substrates among functionally im-
portant cell-surface proteins to understand the exact
contribution of ATPo and ectoenzymes in lympho-
cyte differentiation, development, and effector re-
sponses.
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